Recent Quotes (30 days)

You have no recent quotes
chg | %

Piramal Enterprises Ltd  

(Public, BOM:500302)   Watch this stock  
Find more results for BOM: 500302
2,723.60
-97.50 (-3.46%)
Dec 13 - Close
BOM real-time data - Disclaimer
Currency in INR
Range 2,703.95 - 2,838.05
52 week 1,443.90 - 3,083.05
Open 2,820.75
Vol. 30,700.00
Mkt cap 472.24B
P/E 33.53
Div/yield 21.00/0.77
EPS 81.23
Shares 172.79M
Beta     -
Inst. own     -

Key stats and ratios

Q3 (Sep '17) 2017
Net profit margin 15.13% 14.65%
Operating margin 44.98% 36.46%
EBITD margin - 41.05%
Return on average assets - 3.16%
Return on average equity - 9.00%
Employees 4,013 -
CDP Score - D

Address

10th floor, Piramal Tower Ganpatrao Kadam Marg Lower Parel
MUMBAI, 400013
India
+91-22-30466666 (Phone)
+91-22-24902363 (Fax)

Website links

External links

Description

Piramal Enterprises Limited (PEL) is engaged in the business of pharmaceuticals, including research and development, financial services and information management through its subsidiaries. The Company's pharmaceutical business consists of manufacturing and sale of own and traded bulk drugs and formulations. It operates through three segments: Healthcare, Financial Services and Information Management. Its Healthcare segment includes pharma solutions, critical care, consumer products and imaging. Its Financial Services segment includes wholesale lending, alternative asset management and investments in Shriram Group. Its Information Management segment is engaged in Decision Resources Group (DRG). DRG's product and services portfolio consists of data and analytics, research products and global consulting services. The Company offers its products under brands, including Saridon, Lacto Calamine, i-pill/i-know, Polycrol, Tetmosol, Untox, Stop AllerG and Throatsil.

Officers and directors

Ajay G. Piramal Executive Chairman of the Board
Age: 62
Swati A. Piramal Vice Chairman of the Board
Peter DeYoung Chief Executive Officer - Critical Care
Jonathan M. Sandler Chief Executive Officer - Decision Resources Group
Vivek Sharma CPA Chief Executive Officer - Pharma Solutions
Vivek Valsaraj President - Finance & Account, Chief Financial Officer - Pharma Business
Leonard D'Souza Company Secretary, Compliance Officer
Khushru Jijina Managing Director - Piramal Fund Management
Shantanu Nalavadi Managing Director - Distressed Asset Fund
Nandini Piramal Executive Director